Patents by Inventor Manuel Weinheimer

Manuel Weinheimer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
    Patent number: 11931328
    Abstract: Pharmaceutical compositions including an active ingredient and a stabilizer, as well as methods of manufacture of the compositions, and methods of their use. The composition may include the active ingredient dispersed throughout a matrix of the stabilizer. In some embodiments, the active ingredient and the stabilizer are intimately mixed in a matrix formulation. In some embodiments, the active ingredient is selected from 4 amino-3-(4-chlorophenyl)butanoic acid) (“baclofen”) and its pharmaceutically acceptable salts.
    Type: Grant
    Filed: March 16, 2023
    Date of Patent: March 19, 2024
    Assignee: AMNEAL PHARMACEUTICALS LLC
    Inventors: David Penake, Sharon Hamm, Leonard O'Mahony, John Devane, Wolfgang Mohr, Manuel Weinheimer
  • BACLOFEN FORMULATIONS AND METHODS OF MINIMIZING PATIENT EXPOSURE TO METABOLITE VARIATIONS
    Publication number: 20240082193
    Abstract: Baclofen formulations, including formulations that minimize variability between doses, that minimize variation in patient exposure to baclofen metabolites, and are bioequivalent in regards to baclofen versus M1 metabolite ratios of baclofen tablets.
    Type: Application
    Filed: November 14, 2023
    Publication date: March 14, 2024
    Applicant: AMNEAL PHARMACEUTICALS LLC
    Inventors: Leonard O’MAHONY, Sharon HAMM, John DEVANE, David PENAKE, Wolfgang MOHR, Manuel WEINHEIMER
  • Baclofen formulations and methods of minimizing patient exposure to metabolite variations
    Patent number: 11850225
    Abstract: Baclofen formulations, including formulations that minimize variability between doses, that minimize variation in patient exposure baclofen metabolites, and are bioequivalent in regards to baclofen versus M1 metabolite ratios of baclofen tablets.
    Type: Grant
    Filed: July 11, 2022
    Date of Patent: December 26, 2023
    Assignee: AMNEAL PHARMACEUTICALS LLC
    Inventors: Leonard O'Mahony, Sharon Hamm, John Devane, David Penake, Wolfgang Mohr, Manuel Weinheimer
  • STABILIZED FORMULATIONS OF 4-AMINO-3-SUBSTITUTED BUTANOIC ACID DERIVATIVES
    Publication number: 20230218554
    Abstract: Pharmaceutical compositions including an active ingredient and a stabilizer, as well as methods of manufacture of the compositions, and methods of their use. The composition may include the active ingredient dispersed throughout a matrix of the stabilizer. In some embodiments, the active ingredient and the stabilizer are intimately mixed in a matrix formulation. In some embodiments, the active ingredient is selected from 4 amino-3-(4-chlorophenyl)butanoic acid) (“baclofen”) and its pharmaceutically acceptable salts.
    Type: Application
    Filed: March 16, 2023
    Publication date: July 13, 2023
    Applicant: AMNEAL PHARMACEUTICALS LLC
    Inventors: David PENAKE, Sharon HAMM, Leonard O’MAHONY, John DEVANE, Wolfgang MOHR, Manuel WEINHEIMER
  • Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
    Patent number: 11654124
    Abstract: Pharmaceutical compositions including an active ingredient and a stabilizer, as well as methods of manufacture of the compositions, and methods of their use. The composition may include the active ingredient dispersed throughout a matrix of the stabilizer. In some embodiments, the active ingredient and the stabilizer are intimately mixed in a matrix formulation. In some embodiments, the active ingredient is selected from 4 amino-3-(4-chlorophenyl)butanoic acid) (“baclofen”) and its pharmaceutically acceptable salts.
    Type: Grant
    Filed: May 28, 2020
    Date of Patent: May 23, 2023
    Assignee: AMNEAL PHARMACEUTICALS LLC
    Inventors: David Penake, Sharon Hamm, Leonard O'Mahony, John Devane, Wolfgang Mohr, Manuel Weinheimer
  • STABILIZED FORMULATIONS OF 4-AMINO-3-SUBSTITUTED BUTANOIC ACID DERIVATIVES
    Publication number: 20220265588
    Abstract: Pharmaceutical compositions including an active ingredient and a stabilizer, as well as methods of manufacture of the compositions, and methods of their use. The composition may include the active ingredient dispersed throughout a matrix of the stabilizer. In some embodiments, the active ingredient and the stabilizer are intimately mixed in a matrix formulation. In some embodiments, the active ingredient is selected from 4 amino-3-(4-chlorophenyl)butanoic acid) (“baclofen”) and its pharmaceutically acceptable salts.
    Type: Application
    Filed: May 28, 2020
    Publication date: August 25, 2022
    Applicant: AMNEAL PHARMACEUTICALS LLC
    Inventors: David PENAKE, Sharon HAMM, Leonard O'MAHONY, John DEVANE, Wolfgang MOHR, Manuel WEINHEIMER
  • Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
    Patent number: 10792262
    Abstract: Pharmaceutical compositions including an active ingredient and a stabilizer, as well as methods of manufacture of the compositions, and methods of their use.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: October 6, 2020
    Assignee: SAOL INTERNATIONAL LIMITED
    Inventors: David Penake, Sharon Hamm, Leonard O'Mahony, John Devane, Wolfgang Mohr, Manuel Weinheimer
  • Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
    Patent number: 10751312
    Abstract: Pharmaceutical compositions including an active ingredient and a stabilizer, as well as methods of manufacture of the compositions, and methods of their use.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: August 25, 2020
    Assignee: SAOL INTERNATIONAL LIMITED
    Inventors: David Penake, Sharon Hamm, Leonard O'Mahony, John Devane, Wolfgang Mohr, Manuel Weinheimer